"Platelet-Rich Plasma" Epidural Injection an Emerging Strategy in Lumbar Disc Herniation

• Status: Completed
• Trial end date: 2021-06-30
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the efficacy of platelet-rich plasma (PRP; double-spin) in treatment of single-level lumbar herniated nucleus pulposus (HNP) in comparison to triamcinolone. RCT was conducted with 30 patients included.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Queen Savang Vadhana Memorial Hospital, Thailand
• Treatments: Triamcinolone

Criteria

Inclusion Criteria:

• Age 20-55 years

• Having failed conservative treatment for at least 6 weeks

• Visual analogue scale (VAS) of greater than 30

• Confirmed a single-level HNP, corelated to clinical, by MRI.

Exclusion Criteria:

• Previous spine surgery or epidural injection

• Progressive neurological deficit

• Cauda equina

• Coagulopathy-related conditions

• Associated cervical myelopathy

• Systemic bone and joint diseases